Delivery Order SPE2DB20D2104-SPE2DB25FMSHZ
Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,495.12 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pens on May 27, 2025, with completion scheduled for May 28, 2025. This competitively awarded, firm fixed-price contract requires delivery to the company's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $3,109.35 delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 ml pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of May 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 15, 2025. This firm fixed-price, non-set-aside delivery order, which is due for completion by September 16, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the federal government. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,252.48 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors on October 28, 2025, with completion targeted for October 29, 2025. This non-competitive delivery order carries firm fixed pricing and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens valued at $13,934.62 on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $3,265.08 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens on September 29, 2025, with completion expected by September 30, 2025. This competitive award, which carries no set-aside designation, is issued as a firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 10 mg/0.5 mL pens on October 29, 2025. This competitive, non-set-aside contract has a ceiling value of $9,410.90 with a firm fixed price structure and an ultimate completion date of October 30, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens under a firm fixed-price contract valued at $5,132.40. This non-set-aside award, with an ultimate completion date of October 27, 2025, represents a routine pharmaceutical supply transaction to support federal medical procurement needs. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pen injections in 0.5 mL doses under a firm fixed-price contract. The order, valued at $2,038.95, was competitively awarded without set-aside provisions and is scheduled for completion by September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance location for this delivery order. This award represents a child...
- The Defense Logistics Agency awarded a $2,344.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 2.5 mg/0.5 mL pen injectors on October 28, 2025, with completion scheduled for October 29, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. The...